Many types of human cancers express GH, GHR, IGF-I, and/or IGF-IRs in the tumour or the tumour microenvironment, thus providing an opportunity for GH/IGF-I to act in an endocrine, paracrine, or autocrine manner. Here, GHR is linked to neoplasm.